Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when IRTC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Securities Litigation (new) — Company is settling a securities class action lawsuit for $45 million.
iRhythm settles securities class action for $45M, mostly covered by insurance
Filed June 5, 2026 · Period ending June 3, 2026 · ~1 min read
Key Changes
-
high
Company agreed to pay $45 million to settle class action securities lawsuit without admitting wrongdoing. Settlement includes plaintiff attorneys' fees and dismisses all claims against iRhythm and its CEO.
Item 8.01 view on EDGAR → -
medium
Most of the $45M will be paid by insurers, but payment exhausts remaining coverage under applicable directors and officers policies, leaving no insurance protection for future related claims.
Item 8.01 view on EDGAR → -
medium
Settlement costs will be excluded from non-GAAP metrics like adjusted EBITDA and adjusted operating expenses as a non-recurring item, so adjusted earnings won't reflect the charge.
Item 8.01 view on EDGAR → -
medium
Separate stockholder derivative lawsuits filed on behalf of the company remain pending and unresolved, potentially creating additional future liabilities.
Item 8.01 view on EDGAR → -
low
Settlement requires court approval. Lead plaintiff has filed for preliminary approval, but final acceptance is not guaranteed.
Item 8.01 view on EDGAR →
Summary
iRhythm Technologies agreed to settle a class action securities lawsuit for $45 million, with insurers covering most of the payment. The settlement resolves claims without any admission of fault and will result in complete dismissal of the case once approved by the court.
While this removes a significant legal overhang, the payment exhausts the company's remaining D&O insurance coverage for this matter, leaving no buffer for future related claims. Retail investors should note that management will exclude the settlement from non-GAAP earnings metrics, treating it as a one-time charge. This means adjusted EBITDA and other key performance indicators won't reflect the cost.
However, separate derivative lawsuits filed by shareholders on behalf of the company remain unresolved and could generate additional expenses. Watch for the court's preliminary approval decision and any updates on the pending derivative cases. Also monitor whether iRhythm secures additional D&O insurance coverage, as the current policies are now exhausted.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
The Settlement Agreement does not resolve the previously-disclosed stockholder derivative lawsuits brought by stockholders on behalf of iRhythm Tech.
While this settlement resolves the class action, separate derivative lawsuits filed by shareholders on behalf of the company remain unresolved and could result in additional costs or liabilities.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify